Search

everythinglearnresearchcommunity

for

Search:↓

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

ALRN-6924 may prevent hair loss caused by chemotherapy.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

GABEB is a less severe skin condition caused by a gene mutation affecting collagen, leading to blisters and other symptoms.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Panitumumab can cause excessive ear hair growth.

Oral tranexamic acid is a safe and effective treatment for melasma.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Co-trimoxazole may help treat autoimmune diseases.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Gefitinib can cause rare scarring hair loss.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Longdan Xiegan decoction is more effective than conventional medicine for treating eczema.

Upadacitinib effectively treated severe hair loss in a child.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Mutations in the p63 gene affect skin adhesion, barrier integrity, and hair growth.